+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Topical Hemostat Market Research Report by Product, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 234 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4989882
UP TO OFF until Dec 31st 2022
The Global Topical Hemostat Market size was estimated at USD 3,556.93 million in 2021, USD 3,817.17 million in 2022, and is projected to grow at a CAGR 7.49% to reach USD 5,487.43 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Topical Hemostat to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Collagen-based Topical Hemostats, Combination Topical Hemostats, Gelatin-based Topical Hemostats, Oxidized Regenerated Cellulose-based Topical Hemostats, and Thrombin-based Topical Hemostats.
  • Based on Application, the market was studied across Hospitals, Nursing Homes, and Surgical Centers.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Topical Hemostat market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Topical Hemostat Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Topical Hemostat Market, including Aegis Lifesciences, Arch Therapeutics, Inc., Axio Biosolutions Pvt Ltd, B.Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Biom'up, Cohera Medical, Inc., CryoLife, Inc., Equimedical B.V., GELITA MEDICAL GmbH, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtrade Products Ltd, Medtronic PLC, Meril Life Sciences Pvt. Ltd, Pfizer, Inc., Stryker Corporation, Teleflex Incorporated, and Z-Medica, LLC.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Topical Hemostat Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Topical Hemostat Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Topical Hemostat Market?
4. What is the competitive strategic window for opportunities in the Global Topical Hemostat Market?
5. What are the technology trends and regulatory frameworks in the Global Topical Hemostat Market?
6. What is the market share of the leading vendors in the Global Topical Hemostat Market?
7. What modes and strategic moves are considered suitable for entering the Global Topical Hemostat Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential demand in vascular surgeries across the world
5.1.1.2. Increasing application attributed to its cost-effective nature
5.1.1.3. Growing aging population and related infections
5.1.2. Restraints
5.1.2.1. Dearth of reimbursement policies for these products
5.1.3. Opportunities
5.1.3.1. Emerging demand for minimally invasive surgical procedures
5.1.3.2. Ongoing R&D for the introduction of novel topical hemostat
5.1.4. Challenges
5.1.4.1. High cost of surgical procedures
5.2. Cumulative Impact of COVID-19
6. Topical Hemostat Market, by Product
6.1. Introduction
6.2. Collagen-based Topical Hemostats
6.3. Combination Topical Hemostats
6.4. Gelatin-based Topical Hemostats
6.5. Oxidized Regenerated Cellulose-based Topical Hemostats
6.6. Thrombin-based Topical Hemostats
7. Topical Hemostat Market, by Application
7.1. Introduction
7.2. Hospitals
7.3. Nursing Homes
7.4. Surgical Centers
8. Americas Topical Hemostat Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Topical Hemostat Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Topical Hemostat Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Aegis Lifesciences
12.2. Arch Therapeutics, Inc.
12.3. Axio Biosolutions Pvt Ltd
12.4. B.Braun Melsungen AG
12.5. Baxter International, Inc.
12.6. Becton, Dickinson and Company
12.7. Biom'up
12.8. Cohera Medical, Inc.
12.9. CryoLife, Inc.
12.10. Equimedical B.V.
12.11. GELITA MEDICAL GmbH
12.12. Hemostasis, LLC
12.13. Integra LifeSciences Corporation
12.14. Johnson & Johnson Services, Inc.
12.15. Medtrade Products Ltd
12.16. Medtronic PLC
12.17. Meril Life Sciences Pvt. Ltd
12.18. Pfizer, Inc.
12.19. Stryker Corporation
12.20. Teleflex Incorporated
12.21. Z-Medica, LLC
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL TOPICAL HEMOSTAT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL TOPICAL HEMOSTAT MARKET DYNAMICS
FIGURE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 22. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2027
FIGURE 24. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 32. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2027
FIGURE 34. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. CANADA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. MEXICO TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 40. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2027
FIGURE 42. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 44. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2027
FIGURE 46. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. CHINA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. INDIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. JAPAN TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. THAILAND TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2027
FIGURE 61. FRANCE TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. GERMANY TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. ITALY TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. QATAR TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. SPAIN TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. GLOBAL TOPICAL HEMOSTAT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 73. GLOBAL TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TOPICAL HEMOSTAT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 50. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 51. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 53. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 54. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 56. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 57. CANADA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 59. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 60. MEXICO TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 62. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 63. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 65. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 66. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 67. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 70. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 71. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 73. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 74. CHINA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 76. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 77. INDIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 78. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 79. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 80. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 82. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 83. JAPAN TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 85. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 86. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 88. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 89. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 91. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 92. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 94. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 95. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 97. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 98. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 100. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 101. THAILAND TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 103. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 108. FRANCE TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 110. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 111. GERMANY TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 112. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 113. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 114. ITALY TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 115. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 116. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 117. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 118. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 119. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 120. QATAR TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 121. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 122. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 123. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 124. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 125. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 126. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 127. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 128. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 129. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 130. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 131. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 132. SPAIN TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 134. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 138. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 139. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 140. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 141. GLOBAL TOPICAL HEMOSTAT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 142. GLOBAL TOPICAL HEMOSTAT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 143. GLOBAL TOPICAL HEMOSTAT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 144. GLOBAL TOPICAL HEMOSTAT MARKET RANKING
TABLE 145. GLOBAL TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 146. GLOBAL TOPICAL HEMOSTAT MARKET MERGER & ACQUISITION
TABLE 147. GLOBAL TOPICAL HEMOSTAT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 148. GLOBAL TOPICAL HEMOSTAT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 149. GLOBAL TOPICAL HEMOSTAT MARKET INVESTMENT & FUNDING
TABLE 150. GLOBAL TOPICAL HEMOSTAT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 151. GLOBAL TOPICAL HEMOSTAT MARKET: LICENSE & PRICING

Companies Mentioned

  • Aegis Lifesciences
  • Arch Therapeutics, Inc.
  • Axio Biosolutions Pvt Ltd
  • B.Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Biom'up
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • Equimedical B.V.
  • GELITA MEDICAL GmbH
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medtrade Products Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Pfizer, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Z-Medica, LLC

Methodology

Loading
LOADING...